Wolverine Trading, LLC Humanigen, Inc Put Options Transaction History

Wolverine Trading, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Aug 15, 2022	SELL	$1.76 - $3.33 $71,808 - $135,864	-40,800 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.81 - $3.97 $25,702 - $56,374	14,200 Added 53.38%	40,800 $126,000
Q4 2021 Feb 14, 2022	SELL	$3.66 - $8.22 $117,486 - $263,862	-32,100 Reduced 54.68%	26,600 $104,000
Q3 2021 Nov 12, 2021	BUY	$5.93 - $17.83 $82,427 - $247,836	13,900 Added 31.03%	58,700 $357,000
Q2 2021 Aug 06, 2021	BUY	$13.54 - $22.74 $606,592 - $1.02 Million	44,800 New	44,800 $771,000

558K

Ticker HGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,661,000
Description
Humanigen, Inc., a clinical-stage biopharmaceutical company, focuses on preventing and treating an immune hyper-response called ?cytokine storm'. Lenzilumab is an antibody that binds to and neutralizes granulocyte-macrophage colony-stimulating factor (GM-CSF). The company is developing lenzilumab as a treatment for cytokine storm associated with...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.